PeptiLux Hub: Peptide Science 🔬✨

Researchers identified ROAM1 as a protein that interacts with AMPK and negatively regulates its activity, potentially offering a new target for treating metabolic dysfunction-associated steatotic liver disease. 💡 Why it matters: The study is relevant to the peptide-research community because it involves protein interaction and targeting for therapeutic purposes. 💭 Discussion: How might targeting ROAM1 impact the development of treatments for metabolic dysfunction-associated steatotic liver disease? 🔗 https://pubmed.ncbi.nlm.nih.gov/42518659/ #PeptideResearch